1103 related articles for article (PubMed ID: 15077107)
1. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
Mall M; Grubb BR; Harkema JR; O'Neal WK; Boucher RC
Nat Med; 2004 May; 10(5):487-93. PubMed ID: 15077107
[TBL] [Abstract][Full Text] [Related]
2. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
Mall MA
Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
[TBL] [Abstract][Full Text] [Related]
3. The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease.
Zhou Z; Duerr J; Johannesson B; Schubert SC; Treis D; Harm M; Graeber SY; Dalpke A; Schultz C; Mall MA
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S172-82. PubMed ID: 21658636
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis: a disease of vulnerability to airway surface dehydration.
Boucher RC
Trends Mol Med; 2007 Jun; 13(6):231-40. PubMed ID: 17524805
[TBL] [Abstract][Full Text] [Related]
5. Finally, mice with CF lung disease.
Frizzell RA; Pilewski JM
Nat Med; 2004 May; 10(5):452-4. PubMed ID: 15122239
[No Abstract] [Full Text] [Related]
6. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
Tarran R; Donaldson S; Boucher RC
Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
[TBL] [Abstract][Full Text] [Related]
7. Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.
Noël S; Wilke M; Bot AG; De Jonge HR; Becq F
J Pharmacol Exp Ther; 2008 Jun; 325(3):1016-23. PubMed ID: 18309088
[TBL] [Abstract][Full Text] [Related]
8. Adenosine receptors, cystic fibrosis, and airway hydration.
Com G; Clancy JP
Handb Exp Pharmacol; 2009; (193):363-81. PubMed ID: 19639288
[TBL] [Abstract][Full Text] [Related]
9. HCO3- transport in relation to mucus secretion from submucosal glands.
Joo NS; Krouse ME; Wu JV; Saenz Y; Jayaraman S; Verkman AS; Wine JJ
JOP; 2001 Jul; 2(4 Suppl):280-4. PubMed ID: 11875272
[TBL] [Abstract][Full Text] [Related]
10. Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl- channel function.
Reddy MM; Light MJ; Quinton PM
Nature; 1999 Nov; 402(6759):301-4. PubMed ID: 10580502
[TBL] [Abstract][Full Text] [Related]
11. Lung disease in mice with cystic fibrosis.
Kent G; Iles R; Bear CE; Huan LJ; Griesenbach U; McKerlie C; Frndova H; Ackerley C; Gosselin D; Radzioch D; O'Brodovich H; Tsui LC; Buchwald M; Tanswell AK
J Clin Invest; 1997 Dec; 100(12):3060-9. PubMed ID: 9399953
[TBL] [Abstract][Full Text] [Related]
12. [Physiopathology of cystic fibrosis lung disease].
Chinet T
Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
[TBL] [Abstract][Full Text] [Related]
13. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Mall MA
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome.
Sheridan MB; Fong P; Groman JD; Conrad C; Flume P; Diaz R; Harris C; Knowles M; Cutting GR
Hum Mol Genet; 2005 Nov; 14(22):3493-8. PubMed ID: 16207733
[TBL] [Abstract][Full Text] [Related]
15. Epithelial sodium channel inhibition in primary human bronchial epithelia by transfected siRNA.
Caci E; Melani R; Pedemonte N; Yueksekdag G; Ravazzolo R; Rosenecker J; Galietta LJ; Zegarra-Moran O
Am J Respir Cell Mol Biol; 2009 Feb; 40(2):211-6. PubMed ID: 18723440
[TBL] [Abstract][Full Text] [Related]
16. [Early bronchial inflammation in cystic fibrosis].
Puchelle E
J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
[TBL] [Abstract][Full Text] [Related]
17. An overview of the pathogenesis of cystic fibrosis lung disease.
Boucher RC
Adv Drug Deliv Rev; 2002 Dec; 54(11):1359-71. PubMed ID: 12458149
[TBL] [Abstract][Full Text] [Related]
18. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy.
Hyde SC; Gill DR; Higgins CF; Trezise AE; MacVinish LJ; Cuthbert AW; Ratcliff R; Evans MJ; Colledge WH
Nature; 1993 Mar; 362(6417):250-5. PubMed ID: 7681548
[TBL] [Abstract][Full Text] [Related]
19. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
Moore PJ; Tarran R
Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
[TBL] [Abstract][Full Text] [Related]
20. Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice.
Zhou Z; Treis D; Schubert SC; Harm M; Schatterny J; Hirtz S; Duerr J; Boucher RC; Mall MA
Am J Respir Crit Care Med; 2008 Dec; 178(12):1245-56. PubMed ID: 18849497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
